FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel spirocyclic azaindole derivatives of formula I: , where: one of A stands for N, and the other ones stand for CR7-10; W stands for NR4; X stands for O, S; R1 and R2, independently on each other stand for H; C1-5-alkyl each time saturated, branched or unbranched, non-substituted or monosubstituted with -OC1-6alkyl; phenyl, thienyl, morpholinyl, benzothiophenyl or benzodioxilyl, each time non-substituted or monosubstituted with F, C1-6alkyl; or 5-membered heteroaryl, containing three nitrogen atoms as heteroatoms, substituted with C1-3alkyl; bound with C1-3-alkyl group phenyl non-substituted or monosubstituted with F or C1-6alkyl; R4 stands for H; R5 stands for H; R6 stands for H; R7, R8, R9 and R10 stand for H or CP3; in form of siastereomers, mixtures of diastereomers or separate diastereomer; bases and/or salts of physiologically compatible acids. Compounds are suitable for treatment of a number of diseases, for instance, pain, stress, depressions, etc. Described is method of their obtaining.
EFFECT: compounds are suitable for treatment of a number of diseases, for instance, pain, stress, depressions.
11 cl; 1 tbl; 34 ex
Title | Year | Author | Number |
---|---|---|---|
SPIROCYCLIC CYCLOHEXANE DERIVATIVES | 2008 |
|
RU2484092C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2532545C2 |
SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES | 2009 |
|
RU2503660C2 |
SPIRO(5,5)UNDECANE DERIVATIVES | 2009 |
|
RU2515895C2 |
HYDROXYMETHYL CYCLOHEXYLAMINES | 2009 |
|
RU2514192C2 |
DERIVATIVES OF CIS-TETRAHYDRO-SPIRO(CYCLOHEXANE-1,1'-PYRIDO[3,4-b]INDOLE)-4-AMINE EFFECTIVE IN TREATING NEUROPATHIC AND/OR CHRONIC PAIN | 2011 |
|
RU2592283C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2525236C2 |
SPIROCYCLIC CYCLOHEXANE DERIVATIVES | 2008 |
|
RU2470933C2 |
SUBSTITUTED CYCLOHEXYLDIAMINES | 2009 |
|
RU2526251C2 |
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
Authors
Dates
2012-11-27—Published
2007-07-17—Filed